Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
55 search results for:

Hodgkin lymphoma 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 20-09-2018 | Hodgkin lymphoma | News | Article

    Hormonal biomarker shows ovarian toxicity of Hodgkin lymphoma treatment

    Phase III trial data have highlighted the value of antimüllerian hormone as a biomarker of ovarian toxicity associated with different chemotherapy regimens for advanced Hodgkin lymphoma.

    Published in:
    Lancet Oncol 2018; doi:10.1016/S1470-2045(18)30500-X
  2. 03-08-2018 | Hodgkin lymphoma | News | Article
    News in brief

    ‘Reassuring’ childbirth rate reported for Hodgkin lymphoma survivors

    The birth rate for women who are relapse-free after treatment for Hodgkin lymphoma has risen in recent years, becoming comparable with that of the general population regardless of disease stage or treatment.

  3. 22-03-2018 | FDA | News | Article
    approvalsWatch

    First-line brentuximab vedotin approved for advanced Hodgkin lymphoma

    medwireNews : The US FDA has given approval for the use of the antibody–drug conjugate brentuximab vedotin in patients undergoing chemotherapy for treatment-naïve stage III or IV classical Hodgkin lymphoma.

  4. 12-12-2017 | Hodgkin lymphoma | News | Article

    Brentuximab vedotin may improve outcome in advanced Hodgkin lymphoma

    A treatment regimen incorporating the anti-CD30 antibody–drug conjugate brentuximab vedotin is more effective than standard therapy with doxorubicin, bleomycin, vinblastine, and dacarbazine when used as a frontline therapy in patients with advanced Hodgkin lymphoma, phase III trial data show.

    Published in:
    N Engl J Med 2017; Advance online publication, ASH 2017; Atlanta, Georgia, USA
  5. 05-08-2017 | Lymphoma | Article

    Targeting Immune System Alterations in Hodgkin Lymphoma

    This review by Grover et al. discusses novel immunotherapeutic approaches to treat Hodgkin lymphoma, specifically programmed cell death-1 (PD-1) inhibitors and cellular immunotherapy. Grover NS, Savoldo B. Curr Hematol Malig Rep 2017. doi:10.1007/s11899-017-0398-6

  6. 31-10-2017 | Hodgkin lymphoma | News | Article

    PET-guided treatment de-escalation feasible in Hodgkin lymphoma

    A negative positron emission tomography scan after initial treatment with BEACOPP in escalated doses identifies Hodgkin lymphoma patients suitable for a reduction in the total number of cycles needed, HD18 trial data show.

    Published in:
    Lancet 2017; Advance online publication
  7. 18-11-2016 | Pediatric lymphoma | Article

    Non-Hodgkin lymphoma

    This chapter reviews the clinical and biological characteristics of non-Hodgkin lymphoma occurring in children, adolescents, and young adults, with particular focus on the nuances of disease in adolescents and young adults. Hochberg J et al. In: Cancer in Adolescents and Young Adults . Edited by Bleyer A et al. Springer International Publishing AG, 2017. doi:10.1007/978-3-319-33679-4_4

  8. 03-03-2017 | Hodgkin lymphoma | News | Article

    Prognostic benefit of interim PET questioned in Hodgkin’s lymphoma

    Interim positron emission tomography does not identify high-risk patients with advanced stage Hodgkin’s lymphoma who would benefit from the addition of rituximab to standard chemotherapy, research shows.

    Published in:
    Lancet Oncol 2017; Advance online publication

  9. Small effect of disease, treatment on Hodgkin’s lymphoma-related fatigue

    medwireNews: Persistent fatigue, long after completion of treatment, is common in Hodgkin’s lymphoma survivors, and is largely unrelated to disease stage and treatment type.

  10. 07-02-2016 | Hematologic cancers | Book chapter | Article

    Epidemiology and etiology of non-hodgkin lymphoma

    Chiu BCH & Hou N. In:  Non-Hodgkin Lymphoma . Edited by Evens AM & Blum KA. Springer international Publishing, 2015. doi:10.1007/978-3-319-13150-4_1

  11. 05-12-2014 | Pediatric lymphoma | Article

    Pediatric Hodgkin lymphoma

    In this chapter, Hall et al. review the clinical characteristics of pediatric Hodgkin lymphoma. Hall GW et al. In:  Hodgkin Lymphoma: A Comprehensive Overview .  Edited by Engert A, Younes, A. Springer International Publishing 2015. doi:10.1007/978-3-319-12505-3_14

  12. 02-08-2017 | Lymphoma | Article

    Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen

    Saito B, Nakashima H, Abe M et al. Support Care Cancer 2017. doi:10.1007/s00520-017-3845-y

  13. 05-12-2014 | Hematologic cancers | Book chapter | Article

    Functional imaging in hodgkin lymphoma

    The authors review the functional imaging techniques used for staging and response assessment in Hodgkin lymphoma including the use of positron emission tomography and magnetic resonance imaging. Gallamini A, Hutchings M, & Borra A. In:  Hodgkin Lymphoma . Edited by Engert A & Younes A. Springer International Publishing, 2015. doi:10.1007/978-3-319-12505-3_7

  14. 05-12-2014 | Hematologic cancers | Book chapter | Article

    Quality of life in Hodgkin lymphoma

    Halbsguth TV & Flechtner HH. In:  Hodgkin Lymphoma . Edited by Engert A & Younes A. Springer International Publishing, 2015. doi:10.1007/978-3-319-12505-3_23

  15. 05-12-2014 | Hematologic cancers | Book chapter | Article

    Principles of chemotherapy in hodgkin lymphoma

    In this chapter, the authors summarise the role of chemotherapy and evaluate the efficacy of various chemotherapy regimens for treatment of Hodgkin lymphoma. Johnson P & Straus D. In: Hodgkin Lymphoma . Edited by Engert A, Younes A. Springer International Publishing, 2015. doi:10.1007/978-3-319-12505-3_10

  16. 05-12-2014 | Hematologic cancers | Book chapter | Article

    Principles of radiation therapy for hodgkin lymphoma

    In this chapter, the authors examine principles of radiation therapy and its evolution as a treatment option for patients with Hodgkin lymphoma. Yahalom J & Hoppe RT. In: Hodgkin Lymphoma . Edited by Engert A, Younes A. Springer International Publishing, 2015. doi:10.1007/978-3-319-12505-3_9

  17. 07-02-2015 | Hematologic cancers | Book chapter | Article

    Imaging of non-hodgkin lymphomas: diagnosis and response-adapted strategies

    This review evaluates the use of imaging in patients with non-Hodgkin lymphoma before, during, and after therapy with an insight into future developments in the field including new positron emission tomography tracers. El-Galaly TC & Hutchings M. In:  Non-Hodgkin Lymphoma . Edited by Evens AM & Blum KA. Springer International Publishing, 2015. doi:10.1007/978-3-319-13150-4_5

  18. 25-05-2023 | Checkpoint blockade | News | Article

    Real-world data provide reassurance for ICI use in people with HIV and cancer

    With regard to efficacy, the highest ORRs were observed among participants with nonmelanoma skin cancer, Hodgkin’s lymphoma, or Kaposi’s sarcoma, at 69%, 67%, and 60%, respectively, followed by rates of 47% among those with melanoma and 31% among those with NSCLC.

    Author:
    Shreeya Nanda
    Published in:
    J Clin Oncol 2023; doi:10.1200/JCO.22.02459
  19. 01-10-2021 | EMA | News | Article
    approvalsWatch

    EMA supports extension of pembrolizumab use for advanced TNBC

    The positive opinion in this setting adds to the recommended use of pembrolizumab in patients with melanoma, non-small-cell lung cancer, classical Hodgkin lymphoma, urothelial cancer, head and neck squamous cell carcinoma, renal cell carcinoma, esophageal or gastroesophageal junction adenocarcinoma, and cancer of the colon or rectum. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

    Author:
    Hannah Kitt
  20. 23-07-2021 | Breast cancer | News | Article

    eSMART trial adds support for remote symptom monitoring in people with cancer

    Nearly three-quarters (71.4%) had breast cancer, while the remaining had a diagnosis of colorectal cancer, Hodgkin disease, or non-Hodgkin lymphoma.

    Author:
    Shreeya Nanda
    Published in:
    BMJ 2021; 374 : n1647

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.